Xarelto MDL Lawsuit Update #xarelto / #xareltolawsuit / #xareltobloodthinner / #productliability

Since consolidation in December 2014, Plaintiffs continue to come forward and join in the Xarelto Federal Multidistrict Litigation (MDL) presided over by Judge Eldon Fallon in New Orleans, Louisiana. The Xarelto federal MDL is still in the pretrial stages and the bellwether trials are not expected until early 2017. If you have been injured as a result of taking Xarelto, this is a good time to review and consider your legal claims.

If you have been prescribed Xarelto or injured as a result, please contact The Ahearne Law Firm, PLLC for a free consultation. Call nationwide at (845) 763-4100.

Xarelto was first approved by the FDA in 2011 to prevent blood clots and deep vein thrombosis. Despite strong favorable marketing, many of the current Xarelto lawsuits allege that the drug has dangerous side effects, primarily that the Xarelto causes uncontrollable internal bleeding and serious injuries. Plaintiffs allege that Xarelto is particularly dangerous because there is no antidote that will stop the bleeding, such as Vitamin K.

An increasing number of these Xarelto MDL cases are claiming the wrongful death of a family member as a result of the Xarelto’s anticuagulant effects.

In August 2013 the FDA published a warning that Xarelto may cause uncontrolled bleeding, but Xarelto manufacturers continue to heavily market the drug nonetheless.

Categories: